Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease

Archives of Neurology

Volumn 53, Issue 11, 1996, Pages 1121-1126

  Stern, Yaakov ^a,b   Liu, Xinhua ^b   Albert, Marilyn ^d   Brandt, Jason ^c   Jacobs, Diane M ^a,b   Del Castillo Castaneda, Caridad ^b   Marder, Karen ^a,b   Bell, Karen ^a   Sano, Mary ^a,b   Bylsma, Fred ^c  

^a College of Physicians and Surgeons ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 10344250934     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550110061013     Document Type: Article

References (30)

1. Jacobs D, Sano M, Marder K, et al. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994; 44:1215-1220.
2. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987;37:1649-1653.
3. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer's type. Neurology. 1985;35:1544-1550.
4. Chui HC, Lyness S, Sobel E, et al. Prognostic implications of symptomatic behaviors in Alzheimer's disease. In: Heterogeneity of Alzheimer's Disease. New York, NY: Springer-Verlag NY Inc; 1992:12-24.
5. Mortimer JA, Ebbitt B, Jun SP, Finch MO. Predictors of cognitive and functional decline in patients with probable Alzheimer's disease. Neurology. 1992; 42:1689-1696.
6. Stern Y, Mayeux R, Sano M, Chen J. Prognostic factors for the progression of probable Alzheimer's disease. Bull Clin Neurosci. 1989;54:73-79.
7. Chen JY, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extra-pyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol. 1991;48:1141-1143.
8. Brooks J, Kraemer HC, Tanke ED, Yesavage JA. The methodology of studying decline in Alzheimer's disease. J Am Geriatr Soc. 1993;41:623-628.
9. Morris JC, Edland S, Clark C, et al. The consortium to establish a registry for Alzheimer's disease (CERAD), IV: rate of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993;43:2457-2465.
10. Liu X, Tsai W-Y, Stern Y. A functional decline model for prevalent cohort data. Stat Med. 1996;15:1023-1032.
11. Stern Y, Liu X, Albert M, et al. Application of a growth curve approach to modeling the progression of Alzheimer's disease. Gerontology. 1996;51:M179-M184.
12. Draper N, Smith H. Applied Regression Analysis. 2nd ed. New York, NY: John Wiley &, Sons; 1981.
13. Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the 'Predictors Study'), I: study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord. 1994;7:3-21.
14. McKhann G, Orachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
15. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology. 1981;31:645-650.
16. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
17. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York, NY: The Psychological Corp; 1981.
18. Stern Y, Sano M, Paulson J, Mayeux R. Modified Mini-Mental State Examination: validity and reliability. Neurology. 1987;37(suppl 1):179.
19. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of senile change in the cerebral grey matter of elderly subjects. Br J Psychol. 1968;114:797-811.
20. Stern Y, Mayeux R, Hesdorfer D, Sano M. Measurement and prediction of functional change in Alzheimer's disease. Neurology. 1990;40:8-14.
21. Stern MB, Hurting HI. The clinical characteristics of Parkinson's disease and parkinsonian syndromes: diagnosis and assessment. In: The Comprehensive Management of Parkinson's Disease. New York, NY: PMA Corp; 1978:3-50.
22. Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol. 1991;48:1147-1149.
23. Fahn S. Parkinsonism. In: Rowland LP, ed. Merritt's Textbook of Neurology. 9th ed. Media, Pa: Williams & Wilkins; 1995:713-730.
24. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology. 1993;43:2184-2188.
25. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs and incident dementia: a follow-up analysis. Neurology. 1995;45:1942.
26. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology. 1990;40:1-7.
27. Richards M, Bell K, Dooneief G, et al. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology. 1993;43:1708-1711.
28. Ditter SM, Mira SS. Parkinson's disease features in Alzheimer's disease: a neuropathologic and clinical study. Neurology. 1987;37:754-760.
29. Kosaka K, Tsuchiya K, Yoshimura M. Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol. 1988;7:299-305.
30. Gibb WR, Mountjoy CQ, Mann DMA, Lees AJ. A pathological study of the association between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1989;52:701-708.